Pharmacogenomics: The Intersection of Genomics, Pharmacology, and Clinical Medicine

Pharmacogenomics, the study of how genetic variations affect an individual's response to drugs, has emerged as a crucial field in modern medicine. By integrating genomics, pharmacology, and clinical medicine, pharmacogenomics aims to personalize treatment strategies, improve drug efficacy, and reduce adverse reactions. This review article provides an overview of the current state of pharmacogenomics, highlighting its applications in clinical practice, drug development, and precision medicine. We discuss the key concepts, methodologies, and technologies driving the field, including genome-wide association studies, next generation sequencing, and machine learning algorithms. Furthermore, we examine the challenges and opportunities in translating pharmacogenomics research into clinical practice, including the need for standardized guidelines, regulatory frameworks, and education for healthcare professionals. By exploring the intersection of genomics, pharmacology, and clinical medicine, this article aims to provide a comprehensive understanding of pharmacogenomics and its potential to transform the way we approach patient care.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-03
DOI
https://doi.org/10.5281/zenodo.17511371
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacogenomics: The Intersection of Genomics, Pharmacology, and Clinical Medicine

Zenodo (CERN European Organization for Nuclear Research)
Pharmacogenetics and Drug Metabolism
article

Pharmacogenomics: The Intersection of Genomics, Pharmacology, and Clinical Medicine

article en

Abstract

Pharmacogenomics, the study of how genetic variations affect an individual's response to drugs, has emerged as a crucial field in modern medicine. By integrating genomics, pharmacology, and clinical medicine, pharmacogenomics aims to personalize treatment strategies, improve drug efficacy, and reduce adverse reactions. This review article provides an overview of the current state of pharmacogenomics, highlighting its applications in clinical practice, drug development, and precision medicine. We discuss the key concepts, methodologies, and technologies driving the field, including genome-wide association studies, next generation sequencing, and machine learning algorithms. Furthermore, we examine the challenges and opportunities in translating pharmacogenomics research into clinical practice, including the need for standardized guidelines, regulatory frameworks, and education for healthcare professionals. By exploring the intersection of genomics, pharmacology, and clinical medicine, this article aims to provide a comprehensive understanding of pharmacogenomics and its potential to transform the way we approach patient care.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 37%
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacogenomics: The Intersection of Genomics, Pharmacology, and Clinical Medicine · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS